|
Fig. 1: Workflow of the BacMam-enabled cellular assay platform using LanthaScreen® TR-FRET technology
For more information on how we have used this platform to interrogate post translational modifications of p53 and histone H3, download the poster we recently presented at ELRIG: Mac Donald et al.
If you would like to more details on our extended range of cellular assay kits, please contact us >
|